menu
    • menu

    Company profile for Travere Therapeutics

    NEW Drugs in Dev: 4
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Travere Therapeutics, our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. At Travere Therapeutics, we come to work every day to make a difference in the lives of the patients we serve. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therap...
    At Travere Therapeutics, our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. At Travere Therapeutics, we come to work every day to make a difference in the lives of the patients we serve. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. We come together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Travere TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3721 Valley Centre Drive, Suite 200 San Diego, CA 92130
    Telephone
    Telephone
    888-969-7879 (RTRX)
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://travere.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/travererare/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    MAGHREB Pharma Expo

    MAGHREB Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    MAGHREB Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Travere's Drug For Rare Kidney Disease Gets Expanded FDA Approval
    Travere's Drug For Rare Kidney Disease Gets Expanded FDA Approval

    14 Apr 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-expands-approval-travere-therapeutics-drug-rare-kidney-disease-2026-04-13/

    REUTERS
    14 Apr 2026
    Share Share
    Travere Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
    Travere Reports Inducement Grants Under Nasdaq LR 5635(c)(4)

    14 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260414450669/en/Travere-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    14 Apr 2026
    Share Share
    Travere Therapeutics Reports Q4 & Full Year 2025 Financial Result
    Travere Therapeutics Reports Q4 & Full Year 2025 Financial Result

    19 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260219846659/en/Travere-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results

    BUSINESSWIRE
    19 Feb 2026
    Share Share
    Travere Therapeutics Reports Q4, Full-Year 2025 Results
    Travere Therapeutics Reports Q4, Full-Year 2025 Results

    12 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260212107864/en/Travere-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results

    BUSINESSWIRE
    12 Feb 2026
    Share Share
    Travere Therapeutics Issues Inducement Grants Under Nasdaq Rules
    Travere Therapeutics Issues Inducement Grants Under Nasdaq Rules

    11 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260211853379/en/Travere-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    11 Feb 2026
    Share Share
    Travere Therapeutics To Present At Guggenheim Biotech Summit 2026
    Travere Therapeutics To Present At Guggenheim Biotech Summit 2026

    04 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260204548656/en/Travere-Therapeutics-to-Present-at-the-Guggenheim-Emerging-Outlook-Biotech-Summit

    BUSINESSWIRE
    04 Feb 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search